litlas
Log inCreate account

Wouter W. de Herder

Active 1994–2025

Also published as
Wouter W de Herder
160
Papers
30,139
Citations
95
h-index
157
i10-index

Citations

Citations per year for Wouter W. de Herder1971: 2 citations1977: 1 citations1984: 3 citations1993: 1 citations1995: 2 citations1996: 3 citations1997: 14 citations1998: 23 citations1999: 30 citations2000: 28 citations2001: 43 citations2002: 52 citations2003: 67 citations2004: 92 citations2005: 77 citations2006: 94 citations2007: 125 citations2008: 172 citations2009: 180 citations2010: 244 citations2011: 222 citations2012: 259 citations2013: 235 citations2014: 237 citations2015: 284 citations2016: 207 citations2017: 238 citations2018: 265 citations2019: 808 citations2020: 884 citations2021: 736 citations2022: 602 citations2023: 467 citations2024: 827 citations2025: 327 citations2026: 3 citations1972–1976: no citations, so these years are not shown1978–1983: no citations, so these years are not shown1985–1992: no citations, so these years are not shown1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,566 citing papers, 19.1% of this breakdownItaly: 820 citing papers, 10% of this breakdownGermany: 688 citing papers, 8.4% of this breakdownUnited Kingdom: 553 citing papers, 6.7% of this breakdownNetherlands: 544 citing papers, 6.6% of this breakdownFrance: 519 citing papers, 6.3% of this breakdownChina: 371 citing papers, 4.5% of this breakdownSwitzerland: 287 citing papers, 3.5% of this breakdownSweden: 260 citing papers, 3.2% of this breakdownCanada: 259 citing papers, 3.1% of this breakdownSpain: 249 citing papers, 3% of this breakdownAustralia: 189 citing papers, 2.3% of this breakdown
0%19.1%Other 23.3%

Institutions

Fields

  • Medicine92.2%
  • Biochemistry, Genetics and Molecular Biology5.6%
  • Neuroscience0.5%
  • Engineering0.3%
  • Materials Science0.3%
  • Immunology and Microbiology0.3%
  • Other0.8%

Topics

  • Neuroendocrine Tumor Research Advances19.4%
  • Lung Cancer Research Studies11.4%
  • Neuroblastoma Research and Treatments7.9%
  • Pituitary Gland Disorders and Treatments7.5%
  • Adrenal and Paraganglionic Tumors6.1%
  • Pancreatic and Hepatic Oncology Research4%
  • Other43.7%

Coauthors

All papers

Open in search
  1. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

    Authors: Guido Rindi, Özgür Mete, Silvia Uccella, Olca Baştürk, Stefano La Rosa, Lodewijk A.A. Brosens, Shereen Ezzat, Wouter W. de Herder, David S. Klimstra, Mauro Papotti, L. Sylvia - Endocrine Pathology 2022 cited by 957

  2. [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study

    Authors: Simron Singh, Daniel Halperin, Sten Myrehaug, Ken Herrmann, Marianne Pavel, Pamela L. Kunz, Beth Chasen, Salvatore Tafuto, Secondo Lastoria, Jaume Capdevila, Amparo García-Burillo, Do‐Youn Oh, Changhoon Yoo, Thorvardur R Halfdanarson, Stephen A. Falk, Ilya Folitar, Yufen Zhang, Paola Aimone, Wouter W. de Herder, Diego Ferone - The Lancet 2024 cited by 324

  3. Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

    Authors: Tessa Brabander, Wouter A. van der Zwan, Jaap J.M. Teunissen, Boen L.R. Kam, Richard A. Feelders, Wouter W. de Herder, Casper H.J. van Eijck, Gaston J H Franssen, Eric P. Krenning, Dik J. Kwekkeboom - Clinical Cancer Research 2017 cited by 604

  4. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

    Authors: Valentina Ambrosini, Jolanta Kunikowska, Eric Baudin, Lisa Bodei, Catherine Bouvier, Jaume Capdevila, Marta Cremonesi, Wouter W. de Herder, Clarisse Dromain, Massimo Falconi, Melpomeni Fani, Stefano Fanti, Rodney J. Hicks, Levent Kabasakal, Gregory Kaltsas, Valerie Lewington, Silvia Minozzi, Michela Cinquini, Kjell Öberg, Wim J.G. Oyen, Dermot O’Toole, Marianne Pavel, Philippe Ruszniewski, Aldo Scarpa, Jonathan Strosberg, Anders Sundin, David Taïeb, Irene Virgolini, Damian Wild, Ken Herrmann, James C. Yao - European Journal of Cancer 2021 cited by 242

  5. Treatment With the Radiolabeled Somatostatin Analog [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate: Toxicity, Efficacy, and Survival

    Authors: Dik J. Kwekkeboom, Wouter W. de Herder, Boen L.R. Kam, Casper H.J. van Eijck, Martijn van Essen, P.P.M. Kooij, Richard A. Feelders, Maarten O. van Aken, Eric P. Krenning - Journal of Clinical Oncology 2008 cited by 1,447

  6. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

    Authors: M. Caplin, Éric Baudin, Piero Ferollà, Pier Luigi Filosso, Mariano Garcı́a-Yuste, Eric Lim, Kjell Öberg, Giuseppe Pelosi, Aurel Perren, Roberta Rossi, William D. Travis, D.K. Bartsch, Jaume Capdevila, Frederico Costa, Jarosław B. Ćwikła, Wouter W. de Herder, Gianfranco Delle Fave, Barbro Eriksson, Massimo Falconi, Diego Ferone, David J. Gross, Ashley Grossman, Tetsuhide Ito, Robert T. Jensen, Gregory Kaltsas, Fahrettin Keleştimur, Réza Kianmanesh, Ulrich Knigge, Beata Kos‐Kudła, Eric P. Krenning, Emmanuel Mitry, M. Nicolson, Juan Manuel O’Connor, Dermot O’Toole, Ulrich-Frank Pape, Marianne Pavel, John Ramage, Éric Raymond, Guido Rindi, Andrea Rockall, Philippe Ruszniewski, Ramón Salazar, Aldo Scarpa, Eva Sedláčková, Anders Sundin, Christos Toumpanakis, Marie‐Pierre Vullierme, Wolfgang Weber, Bertram Wiedenmann, Zeng Zheng-Pei - Annals of Oncology 2015 cited by 699

  7. Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    Authors: Éric Baudin, Martyn Caplin, Rocio García‐Carbonero, Nicola Fazio, Piero Ferollà, Pier Luigi Filosso, Andrea Frilling, Wouter W. de Herder, Dieter Hörsch, Ulrich Knigge, Catharina M. Korse, Eric Lim, Catherine Lombard‐Bohas, Marianne Pavel, Jean‐Yves Scoazec, Anders Sundin, Alfredo Berruti - Annals of Oncology 2021 cited by 256

  8. Gastroenteropancreatic neuroendocrine tumours

    Authors: Irvin M. Modlin, Kjell Öberg, Daniel C. Chung, Robert T. Jensen, Wouter W. de Herder, Rajesh V. Thakker, Martyn Caplin, Gianfranco Delle Fave, Gregory Kaltsas, Eric P. Krenning, Steven F. Moss, Ola Nilsson, Guido Rindi, Ramón Salazar, Philippe Ruszniewski, Anders Sundin - The Lancet Oncology 2008 cited by 1,752

  9. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs

    Authors: Dik J. Kwekkeboom, Eric P. Krenning, Rachida Lebtahi, Paul Komminoth, Beata Kos‐Kudła, Wouter W. de Herder, Ursula Plöckinger - Neuroendocrinology 2009 cited by 349

  10. [177Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors: Primary analysis of the phase 3 randomized NETTER-2 study.

    Authors: Simron Singh, Daniel M. Halperin, Sten Myrehaug, Ken Herrmann, Marianne Pavel, Pamela L. Kunz, Beth Chasen, Jaume Capdevila, Salvatore Tafuto, Do‐Youn Oh, Changhoon Yoo, Stephen Falk, Þorvarður R. Hálfdánarson, Ilya Folitar, Yufen Zhang, Paola Santoro, Paola Aimone, Wouter W. de Herder, Diego Ferone - Journal of Clinical Oncology 2024 cited by 45

  11. Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study

    Authors: Adrian Daly, María A. Tichomirowa, Patrick Pétrossians, Elina Heliövaara, Marie‐Lise Jaffrain‐Rea, Anne Barlier, Luciana Ansaneli Naves, Tapani Ebeling, Auli Karhu, Antti Raappana, Laure Cazabat, Ernesto De Menis, Carmen Fajardo Montañana, Gérald Raverot, Robert J. Weil, Timo Sane, Dominique Maiter, Sebastian Neggers, Maria Yaneva, Antoine Tabarin, Elisa Verrua, Eija Eloranta, Arnaud Murat, Outi Vierimaa, Pasi Salmela, Philippe Émy, Rodrigo A. Toledo, Maria Sabaté, Chiara Villa, Marc Popelier, Roberto Salvatori, Juliet Jennings, A Ferrández Longás, José Ignacio Labarta Aizpún, Marianthi Georgitsi, Ralf Paschke, Cristina L. Ronchi, Matti Välimäki, Carola Saloranta, Wouter W. de Herder, Renato Cozzi, Mirtha Guitelman, Flavia Magri, Maria Stefania Lagonigro, Georges Halaby, Vinciane Corman, Marie-Thérèse Hagelstein, Jean-François Vanbellinghen, Gustavo Barcelos Barra, Anne‐Paule Gimenez‐Roqueplo, Fergus Cameron, Françoise Borson‐Chazot, I. M. Holdaway, S. P. A. Toledo, Günter K. Stalla, Anna Spada, Sabina Zacharieva, Jérôme Bertherat, Thierry Brue, Vincent Bours, Philippe Chanson, Lauri A. Aaltonen, Albert Beckers - The Journal of Clinical Endocrinology & Metabolism 2010 cited by 370

  12. Consensus on biomarkers for neuroendocrine tumour disease

    Authors: Kjell Öberg, Irvin M. Modlin, Wouter W. de Herder, Marianne Pavel, David S. Klimstra, Andrea Frilling, David C. Metz, Anthony P. Heaney, Dik J. Kwekkeboom, Jonathan Strosberg, T Meyer, Steven F. Moss, Kay Washington, Edward M. Wolin, Eric Liu, James R. Goldenring - The Lancet Oncology 2015 cited by 280

  13. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

    Authors: Gianfranco Delle Fave, Dermot O’Toole, Anders Sundín, Babs G. Taal, Piero Ferollà, John Ramage, Diego Ferone, Tetsuhide Ito, Wolfgang Weber, Z. Zheng-Pei, Wouter W. de Herder, Andreas Pascher, Philippe Ruszniewski, all other Vienna Consensus Conference participants - Neuroendocrinology 2016 cited by 492

  14. Subacute haematotoxicity after PRRT with 177Lu-DOTA-octreotate: prognostic factors, incidence and course

    Authors: Hendrik Bergsma, Mark Konijnenberg, Boen L.R. Kam, Jaap J.M. Teunissen, P.P.M. Kooij, Wouter W. de Herder, Gaston J H Franssen, Casper H.J. van Eijck, Eric P. Krenning, Dik J. Kwekkeboom - European Journal of Nuclear Medicine and Molecular Imaging 2015 cited by 179

  15. Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours

    Authors: Wouter A. van der Zwan, Tessa Brabander, Boen L.R. Kam, Jaap J.M. Teunissen, Richard A. Feelders, Johannes Hofland, E. P. Krenning, Wouter W. de Herder - European Journal of Nuclear Medicine and Molecular Imaging 2018 cited by 137

  16. Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE: Incidence, Course, and Predicting Factors in Patients with Gastroenteropancreatic Neuroendocrine Tumors

    Authors: Hendrik Bergsma, Kirsten van Lom, Marc H.G.P. Raaijmakers, Mark Konijnenberg, Boen L. Kam, Jaap J.M. Teunissen, Wouter W. de Herder, Eric P. Krenning, Dik J. Kwekkeboom - Journal of Nuclear Medicine 2017 cited by 135

  17. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

    Authors: Guido Rindi, G. Klöppel, H. Alhman, Martyn Caplin, Anne Couvelard, Wouter W. de Herder, B. Erikssson, Alberto Falchetti, Massimo Falconi, Paul Komminoth, Meike Körner, José Manuel Lopes, A. M. McNicol, Ola Nilsson, Aurel Perren, Aldo Scarpa, J-Y. Scoazec, Bertram Wiedenmann, and all other Frascati Consensus Conference participants - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2006 cited by 1,572

  18. Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors

    Authors: Wouter T. Zandee, Tessa Brabander, Anela Blažević, Boen L.R. Kam, Jaap J.M. Teunissen, Richard A. Feelders, Johannes Hofland, Wouter W. de Herder - The Journal of Clinical Endocrinology & Metabolism 2018 cited by 135

  19. High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma

    Authors: Abhishek Jha, David Taïeb, Jorge A. Carrasquillo, Daniel A. Pryma, Mayank Patel, Corina Millo, Wouter W. de Herder, Jaydira Del Rivero, Joakim Crona, Barry L. Shulkin, Irene Virgolini, Alice P. Chen, Bhagwant Rai Mittal, Sandip Basu, Joseph S. Dillon, Thomas A. Hope, Carina Marí Aparici, Andrei Iagaru, Rodney J. Hicks, Anca M. Avram, Jonathan Strosberg, A. Cahid Civelek, Frank I. Lin, Neeta Pandit‐Taskar, Karel Pacák - Clinical Cancer Research 2021 cited by 91

  20. Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience

    Authors: Roelf Valkema, Marion de Jong, Willem H. Bakker, Wout A. P. Breeman, P.P.M. Kooij, Pieternella J. Lugtenburg, Frank H. de Jong, Arjan Christiansen, Boen L.R. Kam, Wouter W. de Herder, Mats Stridsberg, Jan Lindemans, Geert Ensing, Eric P. Krenning - Seminars in Nuclear Medicine 2002 cited by 433

  21. X-linked acrogigantism syndrome: clinical profile and therapeutic responses

    Authors: Albert Beckers, Maya Lodish, Giampaolo Trivellin, Liliya Rostomyan, Misu Lee, Fábio R. Faucz, Bo Yuan, Catherine S. Choong, Jean-Hubert Caberg, Elisa Verrua, Luciana Ansaneli Naves, Tim Cheetham, Jacques Young, Philippe A. Lysy, Patrick Pétrossians, Andrew Cotterill, Nalini S. Shah, Daniel L. Metzger, Emilie Castermans, Maria Rosaria Ambrosio, Chiara Villa, Natalia Strebkova, Nadia Mazerkina, S. Gaillard, Gustavo Barcelos Barra, Luis Augusto Casulari, Sebastian Neggers, Roberto Salvatori, Marie‐Lise Jaffrain‐Rea, Margaret Zacharin, Beatriz Santamaría, Sabina Zacharieva, Ee Mun Lim, Giovanna Mantovani, Maria Chiara Zatelli, Michael T. Collins, Jean‐François Bonneville, Martha Quezado, Prashant Chittiboina, Edward H. Oldfield, Vincent Bours, Pengfei Liu, Wouter W. de Herder, Natalia S. Pellegata, James R. Lupski, Adrian Daly, Constantine A. Stratakis - Endocrine Related Cancer 2015 cited by 185

  22. ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms

    Authors: John Ramage, Wouter W. de Herder, Gianfranco Delle Fave, Piero Ferollà, Diego Ferone, Tetsuhide Ito, Philippe Ruszniewski, Anders Sundín, Wolfgang Weber, Z. Zheng-Pei, Babs G. Taal, Andreas Pascher, all other Vienna Consensus Conference participants - Neuroendocrinology 2016 cited by 330

  23. Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate

    Authors: Flavio Forrer, Eric P. Krenning, P.P.M. Kooij, Bert F. Bernard, Mark Konijnenberg, Willem H. Bakker, Jaap J.M. Teunissen, Marion de Jong, Kirsten van Lom, Wouter W. de Herder, Dik J. Kwekkeboom - European Journal of Nuclear Medicine and Molecular Imaging 2009 cited by 207

  24. Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly

    Authors: Federico Gatto, Richard A. Feelders, Rob van der Pas, Johan M. Kros, Marlijn Waaijers, Diana Sprij-Mooij, Sebastian Neggers, Aart‐Jan van der Lelij, Francesco Minuto, Steven W. J. Lamberts, Wouter W. de Herder, Diego Ferone, Leo J. Hofland - The Journal of Clinical Endocrinology & Metabolism 2012 cited by 174